IMA Advisory Services’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,095
| Closed | -$43.1K | – | 300 |
|
|
2023
Q2 | $43.1K | Hold |
1,095
| – | – | 0.01% | 184 |
|
|
2023
Q1 | $26.6K | Hold |
1,095
| – | – | 0.01% | 200 |
|
|
2022
Q4 | $23.4K | Hold |
1,095
| – | – | 0.01% | 216 |
|
|
2022
Q3 | $20K | Buy |
+1,095
| New | +$14.4K | 0.01% | 219 |
|
|
2016
Q4 | – | Sell |
-57,691
| Closed | -$2.66M | – | 127 |
|
|
2016
Q3 | $2.66M | Buy |
57,691
+560
| +1% | +$31.6K | 1.52% | 26 |
|
|
2016
Q2 | $2.87M | Sell |
57,131
-9,375
| -14% | -$466K | 1.8% | 17 |
|
|
2016
Q1 | $2.77M | Hold |
66,506
| – | – | 1.61% | 21 |
|
|
2015
Q4 | $5.04M | Buy |
66,506
+445
| +0.7% | +$25.7K | 3.06% | 2 |
|
|
2015
Q3 | $2.62M | Sell |
66,061
-2,289
| -3% | -$121K | 1.66% | 21 |
|
|
2015
Q2 | $3.56M | Buy |
68,350
+420
| +0.6% | +$20.9K | 1.69% | 13 |
|
|
2015
Q1 | $3.16M | Buy |
67,930
+2,940
| +5% | +$153K | 1.54% | 23 |
|
|
2014
Q4 | $2.92M | Buy |
+64,990
| New | +$2.73M | 1.51% | 20 |
|
IMA Advisory Services's ISEE Position: Q3 2023 in Review
IMA Advisory Services sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 1,095 shares — an estimated $43.1K sold.
IMA Advisory Services first reported a position in ISEE in Q4 2014 and held it in 12 quarters. The position peaked at $5.04M in Q4 2015. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- IMA Advisory Services reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- IMA Advisory Services sold 1,095 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $43.1K.
- IMA Advisory Services first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 12 quarters.
- IMA Advisory Services's IVERIC bio, Inc. Common Stock position peaked at $5.04M in Q4 2015.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on IMA Advisory Services's 13F filing for Q3 2023, filed 28 Nov 2023.